NEUMENTUM, INC.

Profile

Company Names

NEUMENTUM, INC.

Addresses

350 SPRINGFIELD AVENUE, SUITE 200, SUMMIT, NJ 07901

39 EAGLE NEST ROAD, MORRISTOWN, NJ 07960

252 COLORADO AVENUE, PALO ALTO, CA 94301

Phone Numbers

9082396142

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$32,502,757.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2021-09-30 
$16,559,757.00 
$20,000,000.00 
$3,440,243.00 
Equity 
4
2019-11-01 
$2,663,000.00 
$7,000,000.00 
$4,337,000.00 
Debt 
3
2019-03-12 
$3,020,000.00 
$7,000,000.00 
$3,980,000.00 
Debt 
2
2018-05-14 
$5,000,000.00 
$10,000,000.00 
$5,000,000.00 
Equity 
1
2017-10-24 
$5,260,000.00 
$6,000,000.00 
$740,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ANDREW 
 
BLANK 
DIRECTOR
NEUMENTUM, INC.
CHRISTINE 
 
CVIJIC 
EXECUTIVE OFFICER, DIRECTOR
NEUMENTUM, INC.
CHRISTINE 
MIKAIL 
CVIJIC 
EXECUTIVE OFFICER, DIRECTOR
NEUMENTUM, INC.   |  NATIVE CARDIO, INC.   |  NEUROGENE INC.
PEDRO 
 
GRANADILLO 
DIRECTOR
NILE THERAPEUTICS, INC.   |  AURA BIOSCIENCES, INC.   |  NEUMENTUM, INC.   |  NATIVE CARDIO, INC.
TAGGART 
 
MCGURRIN 
EXECUTIVE OFFICER
NEUMENTUM, INC.
AUGUST 
 
MORETTI 
DIRECTOR
NEUMENTUM, INC.
JOSEPH 
 
PERGOLIZZI 
DIRECTOR
NEUMENTUM, INC.   |  ENALARE THERAPEUTICS INC.
RICHARD 
SCOTT 
SHIVELY 
EXECUTIVE OFFICER, DIRECTOR
NEUMENTUM, INC.
ILONA 
 
STEIGERWALD 
EXECUTIVE OFFICER
NEUMENTUM, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-04-28
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-09-30 
2021-10-21
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-09-30 
2021-10-14
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-09-30 
2019-11-15
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2019-11-01 
2019-09-06
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2019-03-12 
2019-03-27
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2019-03-12 
2018-05-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-14 
2017-10-31
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-10-24 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
BROOKLINE CAPITAL MARKETS, A DIVISION OF ARCADIA SECURITIES, LLC
44656
NONE
NONE
CIM SECURITIES, LLC
120852
NONE
NONE
ARCADIA SECURITIES, LLC
44656
NONE
NONE
ARCADIA SECURITIES, LLC
44656
NONE
NONE
CIM SECURITIES, LLC
120852
NONE
NONE
BROOKLINE CAPITAL MARKETS, A DIVISION OF CIM SECURITIES, LLC
120852